Case-based learning: pharmacy involvement in congenital heart disease A comprehensive overview of the journey of a patient with congenital heart disease, from foetal to paediatric care, including perspectives from the parents and the medical team.…
Congenital heart disease: an overview An overview of the causes, diagnosis and treatments for congenital heart disease.…
Antidepressants ‘substantially increase risk’ of low blood pressure when standing up in older people, study results suggest Researchers found that patients aged over 60 years who were prescribed selective serotonin re-uptake inhibitors were at a four-fold increased risk of postural hypotension in first four weeks of use.…
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest Researchers found that patients who received a combination treatment of statins and ezetimibe within 12 weeks of a heart attack and lowered their cholesterol to target-level early were less at risk of heart attacks, strokes and deaths.…
NHS increases funding for inclisiran although uptake remains ‘slower than expected’ In a letter sent to colleagues, NHS England said it had increased the reimbursement fee for inclisiran from £50 to £60.…
BMI should be recorded annually for people with long-term conditions, says NICE The draft quality standard on overweight and obesity management also advises healthcare professionals to seek permission in a sensitive, non-judgemental way before discussing weight.…
Two-thirds of cholesterol point-of-care tests fail to meet standards, researchers warn Authors of a literature review found that only two out of six point-of-care tests “mostly met” necessary standards for use in the NHS Health Check programme.…
Case-based learning: nutrition and feeding considerations for hospitalised neonates When neonates are faced with feeding constraints, it is important that pharmacists work effectively within the multidisciplinary team to improve decision-making and provide effective support for mothers and families.…
Standard-dose DOACs not necessarily better than reduced dose, study results suggest Researchers found that “non-inferiority” of a reduced dose of direct oral anticoagulants could not be determined when compared with a standard dose, with “reliably low rates” of recurrent venous thromboembolism.…
Inclisiran prescribed to 7% of expected target population in three years, NHS data reveal Exclusive: The Royal College of General Practitioners and the British Medical Association maintain that caution should be taken when prescribing inclisiran since long-term trial data on the drug will not be available until 2026.…
